Kapoor DU, Garg R, Gaur M, Patel MB, Minglani VV, Prajapati BG, et al. Pediatric drug delivery challenges: enhancing compliance through age-appropriate formulations and safety measures. J Drug Deliv Sci Technol. 2024;96:105720.
Martir J, Flanagan T, Mann J, Fotaki N. Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review. J Pharm Pharmacol. 2017;69(4):384–97.
Article PubMed CAS Google Scholar
Martínez-Terán ME, Hoang-Thi TH, Flament MP. Multiparticulate dosage forms for pediatric use. Pediatr Ther. 2017;7(314):2161–0665.
Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)–a novel solid oral dosage form for paediatric use. Eur J Pharm Biopharm. 2011;78(3):462–9.
Article PubMed CAS Google Scholar
Zajicek A, Fossler MJ, Barrett JS, Worthington JH, Ternik R, Charkoftaki G, Lum S, Breitkreutz J, Baltezor M, Macheras P, Khan M, Agharkar S, MacLaren DD. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS J. 2013;15(4):1072–81.
Article PubMed PubMed Central CAS Google Scholar
Moreira M. Pharmaceutics MSI journal of, 2020. How can oral paediatric formulations be improved? A challenge for the XXI century. Int J Pharm. 2020;590–119905.
Wang B, Yang L, Wang B, Luo C, Wang Y, Wang H, Chen F, Xiang X. Development, in vitro and in vivo evaluation of Racecadotril orodispersible films for pediatric use. AAPS PharmSciTech. 2021;22(1):1–13.
Ivanovska V, Rademaker C, van Dijk L. Pediatric drug formulations: a review of challenges and progress. Pediatrics. 2014;134(2):361–72.
Narang M, Shah D, Akhtar H. Efficacy and safety of Drotaverine hydrochloride in children with recurrent abdominal pain: A randomized placebo controlled trial. Indian Pediatr. 2015;52:847–85152.
Bhise S, Mathure D, Patil MVK. Solubility enhancement of antihypertensive agent by solid dispersion technique. Int J Pharm Life Sci. 2011;2(8):970–5.
Ibrahim M, El-Badry M. Formulation of immediate release pellets containing famotidine solid dispersions. Saudi Pharm J. 2014;22(2):149–56.
Kumar A, Ghosh M, Bithy M, Khan MRI. Development and evaluation of stable Paracetamol loaded solid dispersion with enhanced analgesic and hepatoprotective property. Pharmacol Pharm. 2023;14(4):123–43.
Kilor VA, Sapkal NP, Awari JG, Shewale BD. Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using κ-carrageenan as a pelletizing agent. AAPS PharmSciTech. 2010;11(1):336–43.
Article PubMed PubMed Central CAS Google Scholar
Mandal R, Saini P, Pal R, Pandey P. Coating tablets, compositions, recent advancement and current status: a comprehensive review. J Drug Deliv Ther. 2024;14(10):182–95.
Alburyhi M, Saif A, Noman MA. Domperidone-excipient compatibility studies for advanced drug delivery systems development. World J Biomed Pharm Sci. 2025;12(3):250–69.
Vélaz I, Sánchez M, Martín C, Martínez-Ohárriz MC. Effect of PEG 4000 on the dissolution rate of Naproxen. Eur J Drug Metab Pharmacokinet. 1998;23(2):103–8.
Patel M, Shelke S, Shaikh F, Surti N, Panzade P, Panjwani D. Gastroretentive floating microsponges of mitiglinide: design, preparation, and pharmacokinetic evaluation. J Pharm Innov. 2023;18(3):1500–14.
Shaikh F, Patel M, Shelke S, Patel V, Jani D, Shinde G, et al. Formulation, characterization, optimization, and pharmacokinetic evaluation of Cilnidipine-loaded liquisolid compacts with improved dissolution and bioavailability. J Pharm Innov. 2023;18(2):404–25.
de Souza Candeo E, Scheufele FB, de Cassia Campos Pena A, Dequigiovanni G, Linde GA, Mata G, Colauto NB, Schaker PDC. Fungal lignocellulolytic enzymes: an in Silico and full factorial design approach. World J Microbiol Biotechnol. 2025;41(2).
Schlick-Hasper E, Bethke J, Vogler N, Goedecke T. Flow properties of powdery or granular filling substances of dangerous goods packagings—comparison of the measurement of the angle of repose and the determination of the Hausner ratio. Packag Technol Sci. 2022;35(10):765–82.
Akseli I, Hilden J, Katz JM, Kelly RC, Kramer TT, Mao C, et al. Reproducibility of the measurement of bulk/tapped density of pharmaceutical powders between pharmaceutical laboratories. J Pharm Sci. 2019;108(3):1081–4.
Article PubMed CAS Google Scholar
Vertomrnen J, industrial, RKD development. and, 1997 undefined. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Taylor & FrancisJ Vertomrnen, R KingetDrug development and industrial pharmacy, 1997•Taylor & Francis. 1997;23(1):39–46.
Hill SW, Varker AS, Karlage K, Myrdal PB. Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications. J Manag Care Pharm. 2015;15(3):253–61.
Brniak W, Jachowicz R, Pelka P. The practical approach to the evaluation of methods used to determine the disintegration time of orally disintegrating tablets (ODTs). Saudi Pharm J. 2015;23(4):437–43.
Article PubMed PubMed Central Google Scholar
Louis MM, Badawy AA, Nessem DI, Abd Elmalak NS. Drotaverine hydrochloride gastroretentive floating mini-tablets: formulation, in-vitro and in-vivo evaluation. J Drug Deliv Sci Technol. 2020;57:101733.
Ekenna IC, Abali SO. Comparison of the use of kinetic model plots and DD solver software to evaluate the drug release from Griseofulvin tablets. J Drug Deliv Ther. 2022;12(s):5–13.
Guo S, Wang G, Wu T, Bai F, Xu J, Zhang X. Solid dispersion of berberine hydrochloride and Eudragit® S100: formulation, physicochemical characterization and cytotoxicity evaluation. J Drug Deliv Sci Technol. 2017;40:21–7.
Pearnchob N, Bodmeier R. Dry powder coating of pellets with micronized Eudragit® RS for extended drug release. Pharm Res. 2003;20(12):1970–6.
Article PubMed CAS Google Scholar
Thoma K, Bechtold K. Influence of aqueous coatings on the stability of enteric coated pellets and tablets. Eur J Pharm Biopharm. 1999;47(1):39–50.
Article PubMed CAS Google Scholar
Drotaverin. HCl – Neutral Pharma [Internet]. Available from: https://neutralpharma.com/product/drotaverin-hcl/
Pavel IZ, Heller L, Sommerwerk S, Loesche A, Al-Harrasi A, Csuk R. Drotaverine – Concealed Cytostatic! Arch Pharm (Weinheim). 2017;350(1).
Sarode AL, Sandhu H, Shah N, Malick W, Zia H. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug–polymer interactions on supersaturation. Eur J Pharm Sci. 2013;48(3):371–84.
Article PubMed CAS Google Scholar
Patel N, Serajuddin ATM. Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and. Int J Pharm. 2022;616:121532.
Article PubMed CAS Google Scholar
Ambike AA, Mahadik KR, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res. 2005;22(6):990–8.
Article PubMed CAS Google Scholar
Liu C, Desai KG. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions. Pharm Dev Technol. 2005;10(4):467–77.
Article PubMed CAS Google Scholar
Soare AC, Meltzer V, Colbea C, Stanculescu I, Pincu E. Compatibility of Drotaverine hydrochloride with ibuprofen and ketoprofen nonsteroidal anti-inflammatory drugs mixtures. Materials. 2022. https://doi.org/10.3390/ma15031244.
Article PubMed PubMed Central Google Scholar
Gurram R, Gandra S, Shastri NR. Design and optimization of disintegrating pellets of MCC by non-aqueous extrusion process using statistical tools. Eur J Pharm Sci. 2016;84:146–56.
Article PubMed CAS Google Scholar
Dash S, Murthy P, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.
Ahsan W, Alam S, Javed S, Alhazmi HA. Study of drug release kinetics of Rosuvastatin calcium immediate-release tablets marketed in Saudi Arabia. Dissolution Technol. 2022;29:GC1.
Comments (0)